[1] 殷川平, 陈文浩, 莫梓童,等. 黄绵马酸BB对皮肤软组织感染致病菌的抗菌活性及机制研究[J].中草药, 2021, 52(6):1662-1667. [2] 江琰笛,张勇,陶崑,等. 皮肤软组织感染病原菌特征及耐药性分析[J]. 中国卫生检验杂志, 2020, 30(22):20-22. [3] 李丹, 王燕妮, 刘磊,等. 儿童皮肤软组织扩张器相关感染的临床及细菌学特征分析[J]. 中国临床医生杂志, 2020, 48(11):1289-1291. [4] 杨蕉, 李天萍, 杨超,等. 皮肤和软组织感染非结核分枝杆菌的分布和耐药性分析[J]. 中国实验诊断学, 2020, 24(8):1266-1268. [5] 黄焕宜, 谢淑贤, 何国华. BD FX400血培养仪所确定血液感染的微生物种类及检测误差分析[J/CD]. 临床检验杂志(电子版), 2019, 8(2):24-25. [6] 卫菊, 朱秋丽, 孙喆, 等. 碳青霉烯类耐药的铜绿假单胞菌感染对血液病患者病死率的影响[J]. 中华内科杂志, 2020, 59(5):353-359. [7] 冼伟, 杨凡, 李东明, 等. 皮肤及皮肤结构感染细菌种类及耐药性分析[J].中华医学杂志, 2019, 99(11):829-833. [8] RYBAK MJ, ZASOWSKI EJ, TRINH TD, et al.Risk Factors and Outcomes for Bloodstream Infections (BSI) Among Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)[C]//Open Forum Infectious Diseases. Oxford University Press, 2017, 4(Suppl 1): S110. [9] 中国医师协会皮肤科分会. 皮肤及软组织感染诊断和治疗共识[J]. 临床皮肤科杂志, 2009, 38(12):810-812. [10] 李浩, 胡敏, 杨泽华. 988例血流感染病原菌菌谱调查及药物敏感性分析[J]. 中国药物与临床, 2019, 19(19):3406-3408. [11] MARIK PE, LINDE-ZWIRBLE WT, BITTNER EA, et al.Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database[J]. Intensive Care Med, 2017, 43(5): 625-632. [12] 胡凤玲, 李艳艳, 王军大. 糖尿病患者伴侵袭性肺炎克雷伯菌脓毒血症致肝脓肿、多发脑脓肿1例影像学分析[J/CD].新发传染病电子杂志, 2021, 6(2):143-145. [13] SORIANO A, ROSSOLINI GM, PEA F.The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)[J]. Expert Rev Anti Infect Ther, 2020, 18(5): 415-422. [14] WERNER RM, COE NB, QI M, et al.Patient outcomes after hospital discharge to home with home health care vs to a skilled nursing facility[J]. JAMA, 2019, 179(5): 617-623. [15] 潘新锋,池丽俏. 达托霉素联合亚胺培南—西拉司丁钠治疗血液病患者皮肤及软组织感染的疗效及对固有免疫的影响[J].贵州医药, 2022,46(7):1056-1057. [16] XIE J, LI L.Comments on the utilization of Mann-Whitney U test and Kaplan-Meier method[J]. J Gynecol Oncol, 2021, 32(3):e46. [17] HITKA M, KOZUBÍKOVÁ L, POTKÁNY M. Education and gender-based differences in employee motivation[J]. J Bus Ethics, 2018, 19(1): 80-95. [18] BASSETTI M, DEL PUENTE F, MAGNASCO L, et al.Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials[J]. Expert Opin Investig Drugs, 2020, 29(5): 495-506. [19] LODISE TP, REDELL M, ARMSTRONG SO, et al.Efficacy and safety of oritavancin relative to vancomycin for patients with acute bacterial skin and skin structure infections (ABSSSI) in the outpatient setting: results from the SOLO clinical trials[C]//Open forum infectious diseases. Oxford University Press, 2017, 4(1):ofw274. [20] 赖晓兰, 黄传钱, 陈琦, 等. 医院血液科感染患者病原菌分布,耐药性分析及危险因素分析[J]. 中国病原生物学杂志, 2019, 154(10):105-108. [21] 许月芳, 张鑫, 周亮, 等. 氨曲南和万古霉素联合治疗复杂性细菌性皮肤和皮肤软组织感染疗效和安全性的Meta分析[J]. 临床药物治疗杂志, 2017, 15(4):19-24. |